Acute Neurodegeneration and the Inflammasome: Central Processor for Danger Signals and the Inflammatory Response?
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
Activation of the inflammatory response is a crucial event in the adverse outcome of cerebral ischemia, which is promoted by proinflammatory cytokines such as interleukin (IL)-1β. Although caspase-1 is necessary for IL-1β processing, the ‘upstream’ signaling pathways were, until recently, essentially unknown. Fortunately, the inflammasome, a multiprotein complex responsible for activating caspase-1 and caspase-5, has recently been characterized. The activation of the inflammasome can result in one of several consequences such as cytokine secretion, cell death, or the development of a stress-resistant state. The significance of the inflammasome for the initiation of the inflammatory response during systemic diseases has already been shown and members of the inflammasome complex were recently found to be induced in acute brain injury. However, the specific pathophysiologic role of the inflammasome in neurodegenerative disorders still remains to be clarified. The underlying theories (e.g., danger signal theory) along with the signaling pathways that link the inflammasome to acute neurodegeneration will be discussed here. Furthermore, the stimuli that potentially activate the inflammasome in cerebral ischemia will be specified, as well as their relation to well-known pathways activating the innate immune response (e.g., Toll-like receptor signaling) and the consequences that result from their activation (beneficial versus deleterious).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Karikó, K., Buckstein, M., Ni, H., & Weissman, D. (2005) · Immunity · doi:10.1016/j.immuni.2005.06.008 · Cited by 2,728
Agostini, L., Martinon, F., Burns, K., McDermott, M. F., Hawkins, P. N., & Tschopp, J. (2004) · Immunity · doi:10.1016/s1074-7613(04)00046-9 · Cited by 1,768 · cited 2×
“Three autosomal dominant diseases are associated with a gain-of-function mutation in the NALP3 gene: familial cold autoinflammatory syndrome, Muckle– Wells syndrome, and chronic infantile neurologic cutaneous and articular syndrome (Agostini et al, 2004; Inohara et al, 2005; Ogura et al, 2006).”
Molecular identification of a danger signal that alerts the immune system to dying cells
Shi, Y., Evans, J. E., & Rock, K. L. (2003) · Nature · doi:10.1038/nature01991 · Cited by 1,684
Microglia and inflammation-mediated neurodegeneration: Multiple triggers with a common mechanism
Block, M. L., & Hong, J.-S. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.06.004 · Cited by 1,557 · cited 1×
“These diseases are associated, in variable degrees, with the neuronal damage that is substantially mediated by the inflammatory reaction (Dirnagl et al, 1999; Block and Hong, 2005; Lucas et al, 2006).”
Negative regulation of Toll-like receptor-mediated immune responses
Liew, F. Y., Xu, D., Brint, E. K., & O'Neill, L. A. J. (2005) · Nature Reviews Immunology · doi:10.1038/nri1630 · Cited by 1,509 · cited 2×
“…or the reduced expression of TLRs, the complement system, or downstream signaling molecules (e.g., ASC) (Kariko et al, 2004a; Naiki et al, 2005; Liew et al, 2005; Wald et al, 2003; Zhang et al, 2007; Miggin et al, 2007; Akira and Takeda, 2004; Divanovic et al, 2005; Taxman et al, 2006; Carmody…”
Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration
Pétrilli, V, Papin, S., Dostert, C., Mayor, A., Martinon, F., & Tschopp, J. (2007) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402195 · Cited by 1,445 · cited 4×
“The intracellular K + concentration is known to decrease during hypoxic/ischemic cell injury and, interestingly, NALP3 and NALP1 (but not IPAF) activation has recently been shown to depend on low intracellular K + concentration (Petrilli et al, 2007; Somjen, 2001).”
InfluentialVogl, T., Tenbrock, K., Ludwig, S., Leukert, N., Ehrhardt, C., van Zoelen, M. A. D., Nacken, W., Foell, D., van der Poll, T., Sorg, C., et al. (2007) · Nature Medicine · doi:10.1038/nm1638 · Cited by 1,418 · cited 1×
“Myeloidrelated protein-8, an agonist for TLR4 signaling that has recently been identified, represents a further endogenous danger signal (Vogl et al, 2007).”
The role of inflammation in CNS injury and disease
Lucas, S., Rothwell, N. J., & Gibson, R. M. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706400 · Cited by 1,272
Cytoplasmic flagellin activates caspase-1 and secretion of interleukin 1β via Ipaf
Miao, E. A., Alpuche-Aranda, C. M., Dors, M., Clark, A. E., Bader, M. W., Miller, S. I., & Aderem, A. (2006) · Nature Immunology · doi:10.1038/ni1344 · Cited by 1,127 · cited 1×
“ASC is an essential component of most NALPs (it connects the NALPs to caspase-1), and it may also play a role in the IPAF inflammasome (Masumoto et al, 1999, 2001a, b, 2003; Miao et al, 2006).”
mRNA is an endogenous ligand for toll-like receptor 3
Karikó, K., Ni, H., Capodici, J., Lamphier, M., & Weissman, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310175200 · Cited by 1,062 · cited 5×
“…the regulation of TLR signaling in the brain, there is only a small quantity of information available regarding the regulation of the cytosolic surveillance system (Prins et al, 2006; Kariko et al, 2004a; Kielian, 2006; Stevens and Stenzel-Poore, 2006; Hoffmann et al, 2007; Kinoshita et al, 2005).”
InfluentialLehnardt, S., Massillon, L., Follett, P., Jensen, F. E., Ratan, R., Rosenberg, P. A., Volpe, J. J., & Vartanian, T. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1432609100 · Cited by 1,052
Interleukin-1 and neuronal injury
Allan, S. M., Tyrrell, P. J., & Rothwell, N. J. (2005) · Nature Reviews Immunology · doi:10.1038/nri1664 · Cited by 992 · cited 5×
“…been shown to be a key mediator of experimentally induced neurodegeneration and its inhibition has proven to be neuroprotective in vitro and in vivo (Allan et al, 2005; Friedlander et al, 1997; Betz et al, 1996; Pinteaux et al, 2006; Schielke et al, 1998; Boutin et al, 2001; Hara et al, 1997a, b).”
InfluentialChen, C.-J., Kono, H., Golenbock, D., Reed, G., Akira, S., & Rock, K. L. (2007) · Nature Medicine · doi:10.1038/nm1603 · Cited by 876 · cited 1×
“Although there is evidence for a significant contribution of IL-1a in injury-induced inflammation in vivo, most of the data concern the subtype IL-1b (Chen et al, 2007).”
CD36 is a sensor of diacylglycerides
Hoebe, K., Georgel, P., Rutschmann, S., Du, X., Mudd, S., Crozat, K., Sovath, S., Shamel, L., Hartung, T., Zähringer, U., et al. (2005) · Nature · doi:10.1038/nature03253 · Cited by 873 · cited 1×
“CD36 has recently been shown to mediate free radical production and tissue injury in cerebral ischemia (Cho et al, 2005; Hoebe et al, 2005).”
HMGB1 SIGNALS THROUGH TOLL-LIKE RECEPTOR (TLR) 4 AND TLR2
Yu, M., Wang, H., Ding, A., Golenbock, D. T., Latz, E., Czura, C. J., Fenton, M. J., Tracey, K. J., & Yang, H. (2006) · Shock · doi:10.1097/01.shk.0000225404.51320.82 · Cited by 832 · cited 1×
“For example, high-mobility group box 1 protein (HMGB1), an endogenous ligand potentially triggering the neuroinflammatory response, has been shown, depending on the cell type examined, to differentially use TLR2 or TLR4 signaling for IL release (Yu et al, 2006).”
Fisher, C. J. (1994) · JAMA · doi:10.1001/jama.1994.03510470040032 · Cited by 790 · cited 2×
“…episodes of fever, skin rashes, and tissue inflammation, and there is a possibility that they might be treated with the IL-1 antagonist anakinra (Fisher et al, 1994; Liao et al, 1984; Dinarello, 2005; Braddock and Quinn, 2004; Goldbach-Mansky et al, 2006; Hawkins et al, 2004; Hoffman et al,…”
Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits
Tang, S.-C., Arumugam, T. V., Xu, X., Cheng, A., Mughal, M. R., Jo, D. G., Lathia, J. D., Siler, D. A., Chigurupati, S., Ouyang, X., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702553104 · Cited by 779
TLRs, NLRs and RLRs: a trinity of pathogen sensors that co-operate in innate immunity
Creagh, E. M., & O’Neill, L. A. J. (2006) · Trends in Immunology · doi:10.1016/j.it.2006.06.003 · Cited by 762 · cited 6×
“Various PAMPs activate individual TLRs: TLR2 is essential for the recognition of lipopeptides, peptidoglycan, or lipoteichoic acid, TLR4 recognizes lipopolysaccharide (LPS), TLR3 is activated by doublestranded viral RNA, TLR5 mediates the recognition of flagellin, TLR9 recognizes unmethylated CpGcontaining DNA, and TL…”
BackgroundInfluentialA pilot study of IL-1 inhibition by anakinra in acute gout
So, A., De Smedt, T., Revaz, S., & Tschopp, J. (2007) · Arthritis Research & Therapy · doi:10.1186/ar2143 · Cited by 727 · cited 1×
“…in clinical treatments for autoinflammatory diseases such as rheumatoid arthritis or gout (Dinarello, 2005; Fisher et al, 1994; Liao et al, 1984; So et al, 2007; Braddock and Quinn, 2004; Hauff et al, 2005) and recent results of a phase II study of IL-1Ra treatment in stroke patients add much…”
Kummer, J. A., Broekhuizen, R., Everett, H., Agostini, L., Kuijk, L., Martinon, F., Bruggen, R. V., & Tschopp, J. (2007) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.6a7101.2006 · Cited by 531 · cited 4×
“…recently been detected in different cells in the brain, some of which (e.g., caspase-11; RICK/RIP2) are highly inducible under ischemic conditions (Kummer et al, 2007; Zhang et al, 2003; Kang et al, 2000), whereas others, such as TLR4, might alter the cellular distribution under ischemic…”
InfluentialPathophysiology and therapy of experimental stroke
Hossmann, K.-A. (2006) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-006-9008-1 · Cited by 475
Franchi, L., Kanneganti, T.-D., Dubyak, G. R., & Núñez, G. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610762200 · Cited by 356 · cited 1×
“…hemichannel pannexin-1 and leads to potassium efflux, plasma membrane depolarization, cell swelling , and disaggregation of the cytoskeletal network (Khakh and North, 2006; Kanneganti et al, 2007; Martinon and Tschopp, 2007; Kahlenberg and Dubyak, 2004; Franchi et al, 2007; Solle et al, 2001).”
Stenzel-Poore, M. P., Stevens, S. L., King, J. S., & Simon, R. P. (2007) · Stroke · doi:10.1161/01.str.0000251444.56487.4c · Cited by 192
COPs and POPs: modulators of inflammasome activity
Stehlik, C., & Dorfleutner, A. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.12.7993 · Cited by 130
Izuishi, K., Tsung, A., Jeyabalan, G., Critchlow, N. D., Li, J., Tracey, K. J., Demarco, R. A., Lotze, M. T., Fink, M. P., Geller, D. A., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.12.7154 · Cited by 116
Cited by
The Inflammasomes: Guardians of the Body
Martinon, F., Mayor, A., & Tschopp, J. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132715 · Cited by 2,436
“IL-1 is a key mediator of experimentally induced neurodegeneration, and its inhibition is neuroprotective in vitro and in vivo (246, 248).”
BackgroundThe Adverse Effects of Air Pollution on the Nervous System
Genc, S., Zadeoglulari, Z., Fuss, S. H., & Genc, K. (2012) · Journal of Toxicology · doi:10.1155/2012/782462 · Cited by 717
Mezzaroma, E., Toldo, S., Farkas, D., Seropian, I. M., Van Tassell, B. W., Salloum, F. N., Kannan, H. R., Menna, A. C., Voelkel, N. F., & Abbate, A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1108586108 · Cited by 629
Pivotal role of TLR4 receptors in alcohol-induced neuroinflammation and brain damage
Alfonso-Loeches, S., Pascual-Lucas, M., Blanco, A. M., Sanchez-Vera, I., & Guerri, C. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.0976-10.2010 · Cited by 579
Abulafia, D. P., de Rivero Vaccari, J. P., Lozano, J. D., Lotocki, G., Keane, R. W., & Dietrich, W. D. (2009) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2008.143 · Cited by 322
“Oligomerization of procaspase-1 molecules involves the formation of a macromolecular complex known as the inflammasome (Martinon et al, 2002; Trendelenburg, 2008).”
Background
Metadata
- Authors
- Trendelenburg, G.
- Venue
- Journal of Cerebral Blood Flow & Metabolism
- Publisher
- SAGE Publications
- Published
- 2008-01-23
- Volume
- 28
- Issue
- 5
- Pages
- 867-881
- ISSN
- 0271-678X (ISSN-L)
- 1559-7016
- OpenAlex
- W2032156889
- Cited by
- 64
- References
- 25
- FWCI
- 2.85
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.